Enterocolitis in Patients with Cancer Treated with Docetaxel.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Anticancer Research

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.12497PMID 29599375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review

  2017cited by this paper
• Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy.

  2013cited by this paper
• Common Terminology Criteria for Adverse Events (CTCAE) v4.0 Based Hybrid Patient and Physician Questionnaire for Head and Neck (HN) Radiotherapy Symptom Reporting

  2011cited by this paper
• Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy.

  2008cited by this paper
• Colitis in patients with breast carcinoma treated with taxane‐based chemotherapy

  2004cited by this paper
• Typhlitis associated with docetaxel treatment.

  1996cited by this paper
• Neutropenic enterocolitis. Clinical diagnosis and treatment

  1992cited by this paper
• The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia

  1986cited by this paper
• The ileocecal syndrome in acute childhood leukemia.

  1973cited by this paper
• Necrotizing enteropathy: a complication of treated leukemia or lymphoma patients.

  1962cited by this paper

• Adjuvant Anti-tumor Therapy with Polyphenolic Compounds: A Review.

  2024cites this paper
• A decision analysis of cancer patients and the consumption of ready‐to‐eat salad

  2024cites this paper
• Review article: drug‐induced small bowel injury

  2021cites this paper
• Comparative analysis of docetaxel: physical and chemical characterisation of Taxotère® and generics.

  2020cites this paper
• Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations

  2019cites this paper